Nexien BioPharma, Inc. – OTC:NXEN

Add to watchlist

$0.006

+0.00

+7.14%

Market closed

Open in 2 days

-65.91%

month

-65.91%

quarter

-76.50%

year

Market Cap	2.22M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	-0.01
PEG ratio	N/A
EPS	1313.04

Revenue	N/A
EBITDA	-222.36K
Income	82.24B
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Nexien BioPharma, Inc. (OTC:NXEN): Profit margin
Jun 2022	0	-97.00K
Mar 2023	0	82.24B
Jun 2023	0	-93.58K
Mar 2024	0	-53.16K

Nexien BioPharma, Inc. (OTC:NXEN): Debt to assets
Dec 2022	76971	279.29K	362.85%
Mar 2023	58197	288.49K	495.72%
Jun 2023	43127	295.13K	684.34%
Mar 2024	14267	339.55K	2380.02%

Nexien BioPharma, Inc. (OTC:NXEN): Cash Flow
Jun 2022	-23.31K	0
Mar 2023	-14.78K	0
Jun 2023	-19.06K	0
Mar 2024	-20.95K	28.4K

Nexien BioPharma
Insider Trading

Nexien BioPharma, Inc. (OTC:NXEN): Insider trades (number of shares)
Period	Buy	Sel
Apr 2019	0	15000000

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	4 Apr 2019	FRIEDLAND JEFFREY other: Former 10% Owner other: Former 10% Owner	Common Stock	5,000,000	N/A	N/A
Sale	4 Apr 2019	KANATIVA USA INC. 10 percent owner 10 percent owner	Common Stock	5,000,000	$0.09	$425,000
Sale	4 Apr 2019	KANATIVA INC. 10 percent owner 10 percent owner	Common Stock	5,000,000	$0.09	$425,000

NXEN insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Nexien BioPharma stock today?

One share of Nexien BioPharma stock can currently be purchased for approximately $0.01.
When is Nexien BioPharma's next earnings date?

Unfortunately, Nexien BioPharma's (NXEN) next earnings date is currently unknown.
Does Nexien BioPharma pay dividends?

No, Nexien BioPharma does not pay dividends.
How much money does Nexien BioPharma make?

Nexien BioPharma has a market capitalization of 2.22M.
What is Nexien BioPharma's stock symbol?

Nexien BioPharma, Inc. is traded on the OTC under the ticker symbol "NXEN".
What is Nexien BioPharma's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
How do i buy shares of Nexien BioPharma?

Shares of Nexien BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Nexien BioPharma went public?

Nexien BioPharma, Inc. is publicly traded company for more then 24 years since IPO on 11 Jul 2001.
What is Nexien BioPharma's official website?

The official website for Nexien BioPharma is nexienbiopharma.com.
Where are Nexien BioPharma's headquarters?

Nexien BioPharma is headquartered at 4340 East Kentucky Avenue, Glendale, CO.
How can i contact Nexien BioPharma?

Nexien BioPharma's mailing address is 4340 East Kentucky Avenue, Glendale, CO and company can be reached via phone at +30 34957583.

Nexien BioPharma, Inc.

nexienbiopharma.com

Exchange:

OTC

Full time employees:

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. The company is based in Glendale, Colorado.

+30 34957583

4340 East Kentucky Avenue
Glendale, CO 80246

CIK: 0001625288
:
: